David Nicolás

TL;DR: The burden, epidemiology and outcomes of co-infections and superinfections occurring in hospitalized patients with coronavirus disease 2019 (COVID-19) could prove essential in defining the role of empiric antimicrobial therapy or stewardship strategies.

TL;DR: The characteristics and outcomes of 63 patients admitted to a single HaH during the peak of COVID-19 in Barcelona suggest that HaH seems to be a safe and efficacious alternative to conventional hospitalization for accurately selected patients with CO VID-19.

TL;DR: Clinicians should be aware of the possible SARS-CoV-2-pneumococcus association to avoid misdiagnosis and delay antibiotic therapy, and Radiological pattern of COVID-19 can be indistinguishable from that of pneumococcus pneumonia and frequency of co-infection is not well stablished.

TL;DR: Although signature InSTI substitutions were not detected, polymorphisms and substitutions conferring low-level resistance to ralteg Gravir and elvitegravir were frequently found in a baseline genotypic test.

TL;DR: Age, high comorbidity (measured by CCI), and non-performance of surgery were independent predictors of mortality in patients with IE, with no differences in the clinical presentation of IE between the groups.